RxDoctor Payments Data

Danielle Duffy

Adult Health · New Hyde Park, NYNPI 1104570308

Payments from drug & device makers

$2,365in general payments, 2019–2025

Across 101 payments — averaging $23.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$385
  • E.r. Squibb & Sons, L.L.C.$327
  • Novartis$305
  • Novo Nordisk$183
  • Atricure, Inc.$175
  • Medtronic$164
  • plus $827 from 14 others

What the payments were for

  • Food & beverage$2,365100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,365 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban522$531,656
EntrestoSacubitril/Valsartan181$202,994
XareltoRivaroxaban94$116,264
JardianceEmpagliflozin48$53,922
Repatha SureclickEvolocumab45$38,964
Praluent PenAlirocumab21$17,657
FarxigaDapagliflozin Propanediol15$14,258
BrilintaTicagrelor15$13,924
VascepaIcosapent Ethyl19$9,422
Ranolazine ErRanolazine50$8,174
Metoprolol Succinate422$5,531
Rosuvastatin Calcium303$4,321
Atorvastatin Calcium455$3,871
Amlodipine Besylate428$2,975
Carvedilol305$2,818

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$137$531,656522 claims
NovartisEntresto$305$202,994181 claims
Johnson & JohnsonXarelto$160$116,26494 claims
Boehringer IngelheimJardiance$35$53,92248 claims
AstraZenecaFarxiga, Brilinta$106$28,18330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,828 adult health providers in New York.

Other adult health in New Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →